Dual-stress-responsive-pathways prevent HCC initiation via p53 suppression of MTHFD1L-RNA m&lt;sup&gt;6&lt;/sup&gt;A-elicited autonomous growth and immune evasion. Here, TP53 is linked to hepatocellular carcinoma.